2020
DOI: 10.1101/2020.12.29.424712
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Rapid expression of COVID-19 proteins by transient expression in tobacco

Abstract: In 2020 we suffered from a major global pandemic caused by the SARS-CoV-2 coronavirus. Efforts to contain the virus include the development of rapid tests and vaccines, which require a ready supply of viral proteins. Here we report the production of two SARS-CoV-2 proteins by transient transformation of tobacco, leading to high expression within three days, and subsequent purification of the intact proteins. Such efforts may help to develop testing resources to alleviate the major impacts of this global pandem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…Over the last decades, plants have been efficiently used as platforms for the rapid and scalable production of functional recombinant proteins [ 1 ]. Plant-based production of recombinant proteins (e.g., vaccines, therapeutics, diagnostic compounds, industrial enzymes) is now a rapidly developing segment of the bioeconomy, with recent data showing how it can contribute to global responses in emergency scenarios [ 2 ], as was the case for the rapid production of SARS-CoV-2 proteins for COVID-19 research by the transient transformation of tobacco plants [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Over the last decades, plants have been efficiently used as platforms for the rapid and scalable production of functional recombinant proteins [ 1 ]. Plant-based production of recombinant proteins (e.g., vaccines, therapeutics, diagnostic compounds, industrial enzymes) is now a rapidly developing segment of the bioeconomy, with recent data showing how it can contribute to global responses in emergency scenarios [ 2 ], as was the case for the rapid production of SARS-CoV-2 proteins for COVID-19 research by the transient transformation of tobacco plants [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, as compared to stable transgenic production of recombinant proteins in plants, a transient production system offers a faster and higher level of production (Yamamoto et al 2018). Various industrially important proteins have already been successfully produced via transient expression in plants such as α-amylase (Prado et al 2019), Interleukin-6 (Nausch et al 2012), antibodies (Vézina et al 2009), HIV-1 Nef (Lombardi et al 2009), eVLPs (Sainsbury and Lomonossoff 2008), and even COVID-19 proteins (Lindsay et al 2020). Despite its benefits, the plant expression platform has yet to overcome its major challenges in terms of mass production and profitability (Habibi et al 2017).…”
Section: Introductionmentioning
confidence: 99%